Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer
Neeraj Agarwal, Sébastien Rinaldetti, Bassem Ben Cheikh, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 38
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Bladder cancer
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 182
Cancer associated fibroblast derived SLIT2 drives gastric cancer cell metastasis by activating NEK9
Guofang Lu, Rui Du, Jiaqiang Dong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 27
TRIM28 in cancer and cancer therapy
Kailang Li, Haifeng Wang, Bitao Jiang, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 10
Emerging mechanisms of telomerase reactivation in cancer
Shalu Sharma, Shantanu Chowdhury
Trends in cancer (2022) Vol. 8, Iss. 8, pp. 632-641
Open Access | Times Cited: 36
Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
Jianya Huan, Petros Grivas, Jasmine Birch, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1555-1555
Open Access | Times Cited: 31
TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway
Moïra Rossitto, Stephanie Déjardin, Chris M. Rands, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
Tiantian Liu, Shihong Li, Chuanyou Xia, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system
Sándor Spisák, David J. Chen, Pornlada Likasitwatanakul, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials
Yi‐Qing Yang, Shiming Tan, Yaqian Han, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype
Ana Blanca, Antonio López-Beltrán, Kevin Lopez-Porcheron, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2149-2149
Open Access | Times Cited: 12
Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
Maria Lina Tornesello, Andrea Cerasuolo, Noemy Starita, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 12
KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m6A reader YTHDC1 protein degradation
Yi Yang, Yingwen Zhang, Guoyu Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
TRIM28 is an essential regulator of three-dimensional chromatin state underpinning CD8+ T cell activation
Kun Wei, Ruifeng Li, Xiaohong Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis
Dexin Shen, Xiang Yu, Xuefeng Fan, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
TERTpromoter mutations or protein overexpression define an aggressive subset with favourable immunotherapeutic response in advanced urothelial carcinoma
Kaifeng Jin, Jingtong Xu, Lingkai Zhang, et al.
BMJ Oncology (2025) Vol. 4, Iss. 1, pp. e000586-e000586
Open Access
TERT's protective effect on trophoblast cells: reducing mitochondrial ROS
Zongyuan Tian, Xueran Wang, Yingyi Luan, et al.
Reproductive Toxicology (2025), pp. 108899-108899
Closed Access
A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28
Teng Fang, Lanting Liu, Hao Sun, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
Zhenda Wang, Mierxiati Abudurexiti, Wenkai Zhu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer
Andrew McKinney, Radhika Mathur, Nicholas Stevers, et al.
Cell Reports (2022) Vol. 40, Iss. 12, pp. 111344-111344
Open Access | Times Cited: 16
Photodynamic Diagnosis and Therapy in Non-Muscle-Invasive Bladder Cancer
Atsushi Kurabayashi, Hideo Fukuhara, Kaoru Furihata, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2299-2299
Open Access | Times Cited: 3
Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review
Zhouting Tuo, Ying Zhang, Dengxiong Li, et al.
Pharmacological Research (2024) Vol. 206, pp. 107302-107302
Open Access | Times Cited: 3
Tumor-suppressive activities for pogo transposable element derived with KRAB domain via ribosome biogenesis restriction
Zhenbo Tu, Mahmoud A. Bassal, George W. Bell, et al.
Molecular Cell (2024) Vol. 84, Iss. 21, pp. 4209-4223.e6
Closed Access | Times Cited: 3
Targeting visualization of malignant tumor based on the alteration of DWI signal generated by hTERT promoter–driven AQP1 overexpression
Liang Zhang, Mingfu Gong, Sheng Lei, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 7, pp. 2310-2322
Closed Access | Times Cited: 14
TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region
Hamid Pakmanesh, Seyed Omidreza Anvari, Nathalie Forey, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14319-14319
Open Access | Times Cited: 13
Research progress of small-molecule drugs in targeting telomerase in human cancer and aging
Ziyi Shen, Yuanhui Wang, Guanzhen Wang, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110631-110631
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top